Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Total Current Liabilities (2020 - 2026)

NeuroPace has reported Total Current Liabilities over the past 7 years, most recently at $16.2 million for Q1 2026.

  • For Q1 2026, Total Current Liabilities rose 9.93% year-over-year to $16.2 million; the TTM value through Mar 2026 reached $16.2 million, up 9.93%, while the annual FY2025 figure was $17.8 million, 17.54% up from the prior year.
  • Total Current Liabilities for Q1 2026 was $16.2 million at NeuroPace, down from $17.8 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $19.6 million in Q3 2025 and troughed at $9.4 million in Q3 2022.
  • A 5-year average of $13.8 million and a median of $13.1 million in 2024 define the central range for Total Current Liabilities.
  • Biggest five-year swings in Total Current Liabilities: soared 49.82% in 2022 and later fell 18.1% in 2023.
  • Year by year, Total Current Liabilities stood at $11.0 million in 2022, then soared by 47.86% to $16.2 million in 2023, then dropped by 6.61% to $15.2 million in 2024, then grew by 17.54% to $17.8 million in 2025, then decreased by 9.24% to $16.2 million in 2026.
  • Business Quant data shows Total Current Liabilities for NPCE at $16.2 million in Q1 2026, $17.8 million in Q4 2025, and $19.6 million in Q3 2025.